Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Jun 1;157(6):1828–1843. doi: 10.1084/jem.157.6.1828

Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro

PMCID: PMC2187024  PMID: 6854209

Abstract

Previous studies have shown that eosinophils from eosinophilic individuals differ functionally from those of normal individuals. In order to test whether agents that might induce eosinophilia could also affect eosinophil function, we have compared the capacity of culture supernatants from mononuclear cells of eosinophilic or normal individuals to enhance eosinophil activity, as reflected by an increased killing of schistosomula of Schistosoma mansoni in vitro. An enhancing activity was detected, which increased both the antibody- dependent, and to some extent the antibody-independent killing of schistosomula by eosinophils, in the absence of complement. Under similar conditions, the supernatants failed to stimulate an otherwise undetectable neutrophil-mediated killing. The activity could be removed from the assay by washing, without reversing previous eosinophil stimulation, and was not directly toxic to the schistosomula. Preliminary characterization of the activity indicated that it was relatively heat-stable at 100 degrees C for 30 min, and had an estimated molecular weight of 35,000-45,000 as judged by G-200 Sephadex fractionation. The activity was produced by a nonlymphocytic, nonspecific esterase-containing adherent mononuclear cell in the absence of either Con A or antigenic stimulation. Significant enhancing activity was detectable after 1 h of culture and continued for at least 25 h. Protein synthesis was required for its production or release. Although the activity was detectable in supernatants from both eosinophilic and normal individuals, the supernatants that demonstrated highest activity and that could be titrated out furthest were generally derived from eosinophilic individuals, suggesting that there might be some association between eosinophilia and enhanced eosinophil function.

Full Text

The Full Text of this article is available as a PDF (947.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anwar A. R., Kay B. Enhancement of human eosinophil complement receptors by pharmacologic mediators. J Immunol. 1978 Oct;121(4):1245–1250. [PubMed] [Google Scholar]
  2. Anwar A. R., McKean J. R., Smithers S. R., Kay A. B. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. J Immunol. 1980 Mar;124(3):1122–1129. [PubMed] [Google Scholar]
  3. Basten A., Beeson P. B. Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med. 1970 Jun 1;131(6):1288–1305. doi: 10.1084/jem.131.6.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burgess A. W., Metcalf D., Russell S. H., Nicola N. A. Granulocyte/macrophage-, megakaryocyte-, eosinophil- and erythroid-colony-stimulating factors produced by mouse spleen cells. Biochem J. 1980 Feb 1;185(2):301–314. doi: 10.1042/bj1850301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butterworth A. E., Sturrock R. F., Houba V., Mahmoud A. A., Sher A., Rees P. H. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature. 1975 Aug 28;256(5520):727–729. doi: 10.1038/256727a0. [DOI] [PubMed] [Google Scholar]
  6. Butterworth A. E., Sturrock R. F., Houba V., Rees P. H. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature. 1974 Dec 6;252(5483):503–505. doi: 10.1038/252503a0. [DOI] [PubMed] [Google Scholar]
  7. Capron M., Rousseaux J., Mazingue C., Bazin H., Capron A. Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula. J Immunol. 1978 Dec;121(6):2518–2525. [PubMed] [Google Scholar]
  8. Clegg J. A., Smithers S. R. The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro. Int J Parasitol. 1972 Mar;2(1):79–98. doi: 10.1016/0020-7519(72)90036-7. [DOI] [PubMed] [Google Scholar]
  9. Colley D. G. Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol. 1973 May;110(5):1419–1423. [PubMed] [Google Scholar]
  10. Colley D. G. Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promoter. Cell Immunol. 1976 Jun 15;24(2):328–335. doi: 10.1016/0008-8749(76)90216-1. [DOI] [PubMed] [Google Scholar]
  11. David J. R., Vadas M. A., Butterworth A. E., de Brito P. A., Carvalho E. M., David R. A., Bina J. C., Andrade Z. A. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med. 1980 Nov 13;303(20):1147–1152. doi: 10.1056/NEJM198011133032004. [DOI] [PubMed] [Google Scholar]
  12. Dessein A. J., Vadas M. A., Nicola N. A., Metcalf D., David J. R. Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med. 1982 Jul 1;156(1):90–103. doi: 10.1084/jem.156.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Golde D. W., Cline M. J. Identification of the colony-stimulating cell in human peripheral blood. J Clin Invest. 1972 Nov;51(11):2981–2983. doi: 10.1172/JCI107124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Greene B. M., Colley D. G. Eosinophils and immune mechanisms. II. Partial characterization of the lymphokine eosinophil stimulation promoter. J Immunol. 1974 Sep;113(3):910–917. [PubMed] [Google Scholar]
  15. Mahmoud A. A., Stone M. K., Kellermeyer R. W. Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. J Clin Invest. 1977 Sep;60(3):675–682. doi: 10.1172/JCI108819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Metcalf D., Parker J., Chester H. M., Kincade P. W. Formation of eosinophilic-like granulocytic colonies by mouse bone marrow cells in vitro. J Cell Physiol. 1974 Oct;84(2):275–289. doi: 10.1002/jcp.1040840214. [DOI] [PubMed] [Google Scholar]
  17. Miller A. M., Colley D. G., McGarry M. P. Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature. 1976 Aug 12;262(5569):586–587. doi: 10.1038/262586a0. [DOI] [PubMed] [Google Scholar]
  18. Mizel S. B. Interleukin 1 and T cell activation. Immunol Rev. 1982;63:51–72. doi: 10.1111/j.1600-065x.1982.tb00411.x. [DOI] [PubMed] [Google Scholar]
  19. Nicola N. A., Metcalf D., Johnson G. R., Burgess A. W. Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood. 1979 Sep;54(3):614–627. [PubMed] [Google Scholar]
  20. Ponzio N. M., Speirs R. S. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid. Immunology. 1975 Feb;28(2):243–251. [PMC free article] [PubMed] [Google Scholar]
  21. Vadas M. A., David J. R., Butterworth A., Pisani N. T., Siongok T. A. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol. 1979 Apr;122(4):1228–1236. [PubMed] [Google Scholar]
  22. Walls R. S., Basten A., Leuchars E., Davies A. J. Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J. 1971 Jul 17;3(5767):157–159. doi: 10.1136/bmj.3.5767.157. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES